98%
921
2 minutes
20
Background: Limited research exists to guide clinical decisions about trialling, selecting, implementing and evaluating eye-gaze control technology. This paper reports on the outcomes of a Delphi study that was conducted to build international stakeholder consensus to inform decision making about trialling and implementing eye-gaze control technology with people with cerebral palsy.
Methods: A three-round online Delphi survey was conducted. In Round 1, 126 stakeholders responded to questions identified through an international stakeholder Advisory Panel and systematic reviews. In Round 2, 63 respondents rated the importance of 200 statements generated by in Round 1. In Round 3, 41 respondents rated the importance of the 105 highest ranked statements retained from Round 2.
Results: Stakeholders achieved consensus on 94 of the original 200 statements. These statements related to person factors, support networks, the environment, and technical aspects to consider during assessment, trial, implementation and follow-up. Findings reinforced the importance of an individualised approach and that information gathered from the user, their support network and professionals are central when measuring outcomes. Information required to support an application for funding was obtained.
Conclusion: This Delphi study has identified issues which are unique to eye-gaze control technology and will enhance its implementation with people with cerebral palsy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874479 | PMC |
http://dx.doi.org/10.1186/s12883-021-02077-z | DOI Listing |
Dev Med Child Neurol
September 2025
Murdoch Children's Research Institute, Parkville, VIC, Australia.
Aim: To examine visual engagement to social stimuli and response to joint attention in young children with neurofibromatosis type 1 (NF1) and typically developing peers (controls).
Method: Forty-five preschool children were studied cross-sectionally (mean age [SD] = 4 years 3 months [10 months]), 25 with NF1 and 20 typically developing controls. Participants passively viewed two eye-tracking paradigms.
eNeuro
September 2025
Institute of Cognitive Science, University of Osnabrück, Osnabrück 49090, Germany.
Current research strives to investigate cognitive processes under natural conditions. Virtual reality and EEG are promising techniques combining naturalistic settings with close experimental control. However, many questions and technical challenges remain, e.
View Article and Find Full Text PDFJ Vis
September 2025
Spinoza Centre for Neuroimaging, Amsterdam, the Netherlands.
We alter our sampling of visual space not only by where we direct our gaze, but also by where and how we direct our attention. Attention attracts receptive fields toward the attended position, but our understanding of this process is limited. Here we show that the degree of this attraction toward the attended locus is dictated not just by the attended position, but also by the precision of attention.
View Article and Find Full Text PDFRadiol Case Rep
November 2025
Division of Neuroradiology, Department of Radiology, University of Washington, Seattle, WA, USA.
The extraocular muscles are integral to voluntary and reflexive eye movements, enabling precise gaze control through the coordinated action of six muscles. Variants in extraocular muscle anatomy, though rare, may contribute to disorders of ocular movement. We report a case of a 20-year-old female presenting with recurrent painful ophthalmoplegic neuropathy found to possess a rare anomalous muscular band between the superior and inferior rectus muscles identified on magnetic resonance imaging of the orbits.
View Article and Find Full Text PDFFront Neurorobot
August 2025
Technology Research Institute, Arrow Technology Company, ZhuHai, China.
Brain-computer interface (BCI) integration with virtual reality (VR) has progressed from single-limb control to multi-limb coordination, yet achieving intuitive tri-manual operation remains challenging. This study presents a consumer-grade hybrid BCI-VR framework enabling simultaneous control of two biological hands and a virtual third limb through integration of Tobii eye-tracking, NeuroSky single-channel EEG, and non-haptic controllers. The system employs e-Sense attention thresholds (>80% for 300 ms) to trigger virtual hand activation combined with gaze-driven targeting within 45° visual cones.
View Article and Find Full Text PDF